24 Oct, 2024 DLA Piper Genomics Series: Navigating Regulatory Challenges in the Era of Cell and Gene Therapies By Marion Abecassis Lyndsey Hudson Nicola Landolfi Ranulf Barman Marion de Galembert +2 more... Show less As healthcare moves towards personalised and precision medicine,[2] cell and gene therapies (CGTs) have emerged as cutting-edge and...
08 Oct, 2024 Introduction to the DLA Piper Genomics Series: An Insight into the ‘Genomics Revolution’ By Marion Abecassis Lyndsey Hudson Kate Black Ruth Faragher +1 more... Show less Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
07 Jun, 2024 DLA Piper Life Sciences Index 2024 By Lyndsey Hudson Marco de Morpurgo Welcome to the first edition of the Life Sciences Index, a study about perceptions of innovation and growth in the life sciences...
18 Apr, 2024 Managed Entry Agreements (MEAs) under scrutiny once more in Belgium By Jean-Christophe Top Joost Haans Marco de Morpurgo Lyndsey Hudson +1 more... Show less Impressive advancements in the pharma industry provide hope to patients affected by debilitating and life-threatening diseases and a...
24 Mar, 2023 Inspirational Women in Life Sciences Series - an interview with Lyndsey Hudson By Lyndsey Hudson Mary Foord-Weston In the second of our Cortex series on Inspirational Women in Life Sciences, we are proud to feature DLA Piper’s very own Dr Lyndsey...
21 Nov, 2022 Inspiring Women in the Life Sciences Industry: what we can learn from them By Lyndsey Hudson As someone who believes strongly in empowering women in the workplace and building a diverse and inclusive culture, I really enjoyed...
16 May, 2022 Innovation, strategy and collaboration aplenty at the LSX World Congress 2022 By Lyndsey Hudson It was really fantastic to attend the LSX World Congress 2022 in London on 10th and 11th May. So many excellent conversations to be had...
26 Jan, 2022 Initiative launched to accelerate EU clinical trials (ACT EU) By Lyndsey Hudson Accelerating Clinical Trials in the EU (ACT EU) was launched a few days ago, with the aim of transforming the way in which clinical...